Abclon is developing novel therapeutic antibodies using proprietary technologies like NEST, AffiMab, and switchable CAR-T.
| Contact Details | 14th floor, 285 Digital-ro, Guro-gu, Seoul (Guro-dong, Ace Twin Tower 1) |
|---|
Find out more companies
Related products
-
-
-
VentureMedigen Human Care
T cell immunotherapies for solid tumors, vaccine safety and natural immunity
-
-
